Document Detail

Circulating maternal testosterone concentrations at 18 weeks of gestation predict circulating levels of antimüllerian hormone in adolescence: a prospective cohort study.
MedLine Citation:
PMID:  20153853     Owner:  NLM     Status:  MEDLINE    
This prospective study was established to determine the impact of maternal circulating androgen levels during normal pregnancy on ovarian function, as determined by early follicular phase antimüllerian hormone (AMH) levels, inhibin B levels, and antral follicle count (AFC) in 244 female offspring in adolescence. Maternal circulating total testosterone levels at 18 weeks' gestation were statistically significantly correlated with early follicular-phase circulating AMH levels in female adolescent offspring, but no other statistically significant correlations were determined among the maternal androgens at 18 or 34 weeks of gestation and the markers of adolescent ovarian function.
Roger Hart; Deborah M Sloboda; Dorota A Doherty; Robert J Norman; Helen C Atkinson; John P Newnham; Jan E Dickinson; Martha Hickey
Related Documents :
12553203 - Lucky girls: unintentional avoidance of adolescent pregnancy among low-income african-a...
9520543 - Circaseptennian (about 7-year) periodicity in the distribution of birth years of nobel ...
236763 - Epidural analgesia, fetal monitoring and the condition of the baby at birth with breech...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-02-13
Journal Detail:
Title:  Fertility and sterility     Volume:  94     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-27     Completed Date:  2010-09-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1544-7     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 American Society for Reproductive Medicine. All rights reserved.
School of Women's and Infants' Health, University of Western Australia, and Women and Infants Research Foundation, King Edward Memorial Hospital, Perth, Western Australia, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Mullerian Hormone / blood*
Cohort Studies
Gestational Age
Maternal-Fetal Exchange / physiology
Polycystic Ovary Syndrome / blood*,  diagnosis*
Pregnancy Trimester, Second / blood*
Prenatal Exposure Delayed Effects / blood*
Prospective Studies
Testosterone / blood*
Reg. No./Substance:
58-22-0/Testosterone; 80497-65-0/Anti-Mullerian Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Structure and solution properties of enzymatically synthesized glycogen.
Next Document:  Decrease of mitochondrial DNA level in sperm from patients infected with human immunodeficiency viru...